C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 413/10 (2006.01) A61K 31/4245 (2006.01) C07D 413/14 (2006.01)
Patent
CA 2488117
The present invention encompasses compounds of Formula I: as well as the pharmaceutically acceptable salts and hydrates thereof. The compounds are useful for treating immune mediated diseases and conditions, such as bone marrow, organ and tissue transplant rejection. Pharmaceutical compositions and methods of use are included.
L'invention concerne des composés représentés par la formule I ainsi que leurs sels et leurs hydrates pharmaceutiquement acceptables. Ces composés sont utiles pour le traitement de maladies et d'affections d'origine immunologique, telles que le rejet de transplantation de la moelle osseuse, d'un organe ou d'un tissu. L'invention concerne également des compositions pharmaceutiques et les méthodes d'utilisation desdites compositions.
Chen Weirong
Hale Jeffrey J.
Li Zhen
Lynch Christopher L.
Mills Sander G.
Gowling Lafleur Henderson Llp
Merck & Co. Inc.
LandOfFree
1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxyla... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxyla..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxyla... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1536740